Cargando…
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICI) were a major clinical advancement that provided an opportunity to improve the prognosis of patients with non-small cell lung cancer (NSCLC). However, programmed death-ligand-1 (PD-L1) expression does not sufficiently predict ICI efficacy i...
Autores principales: | Lim, Jeong Uk, Lee, Eunyoung, Lee, Sang-Yun, Cho, Hyeong Jun, Ahn, Dong Hyuck, Hwang, Yongki, Choi, Joon Young, Yeo, Chang Dong, Park, Chan Kwon, Kim, Seung Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183402/ https://www.ncbi.nlm.nih.gov/pubmed/37197639 http://dx.doi.org/10.21037/tlcr-22-633 |
Ejemplares similares
-
Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)
por: Lee, Sang-Yun, et al.
Publicado: (2023) -
Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea
por: Kang, Hye Seon, et al.
Publicado: (2022) -
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
por: Kim, Hyeong Min, et al.
Publicado: (2021) -
Molecular, Cellular, and Functional Heterogeneity of Retinal and Choroidal Endothelial Cells
por: Kim, Soo Jin, et al.
Publicado: (2023) -
Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis
por: Lim, Jeong Uk, et al.
Publicado: (2022)